Health Care & Life Sciences » Pharmaceuticals | Abbott India Ltd.

Abbott India Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
18,216
22,602
26,088
28,982
32,982
Cost of Goods Sold (COGS) incl. D&A
13,395
16,523
18,689
20,975
23,314
Gross Income
4,821
6,079
7,399
8,006
9,668
SG&A Expense
2,795
3,256
3,740
4,007
4,272
EBIT
1,884
2,829
-
-
5,225
Unusual Expense
-
81
-
42
-
Non Operating Income/Expense
214
97
122
140
276
Pretax Income
2,380
3,444
3,980
4,365
6,215
Income Tax
769
1,154
1,428
1,598
2,203
Consolidated Net Income
1,611
2,290
2,553
2,766
4,012
Net Income
1,611
2,290
2,553
2,766
4,012
Net Income After Extraordinaries
1,611
2,290
2,553
2,766
4,012
Net Income Available to Common
1,611
2,290
2,553
2,766
4,012
EPS (Basic)
75.82
107.75
120.12
130.19
188.81
Basic Shares Outstanding
21
21
21
21
21
EPS (Diluted)
75.82
107.75
120.12
130.19
188.81
Diluted Shares Outstanding
21
21
21
21
21
EBITDA
2,059
2,978
3,740
4,051
5,387
Other Operating Expense
143
6
63
112
172
Non-Operating Interest Income
282
436
506
576
714

About Abbott India

View Profile
Address
16th Floor, Godrej BKC
Mumbai Maharashtra 400051
India
Employees -
Website http://www.abbott.co.in
Updated 09/14/2018
Abbott India Ltd. is a pharmaceutical company, which develops, manufactures and markets pharmaceutical, diagnostic, nutritional, and hospital products. Its products include ebasil, solspre, citrosoda, digenewas, actnew, acuvin, and acevah. The company was founded on August 22, 1944 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.